Stay updated on Nivolumab & Cabozantinib vs Sunitinib in Renal Cell Carcinoma Clinical Trial

Sign up to get notified when there's something new on the Nivolumab & Cabozantinib vs Sunitinib in Renal Cell Carcinoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Nivolumab & Cabozantinib vs Sunitinib in Renal Cell Carcinoma Clinical Trial page

  1. Check
    6 days ago
    No Change Detected
  2. Check
    13 days ago
    Change Detected
    Summary
    No significant updates to the study design, objectives, or results were detected. The changes appear to be routine updates to the list of participating sites.
    Difference
    0.2%
    Check dated 2025-11-03T21:06:10.000Z thumbnail image
  3. Check
    20 days ago
    No Change Detected
  4. Check
    42 days ago
    Change Detected
    Summary
    Adds a government funding lapse notice and updated operating-status references, and upgrades the version from v3.1.0 to v3.2.0.
    Difference
    2%
    Check dated 2025-10-06T05:27:30.000Z thumbnail image
  5. Check
    49 days ago
    Change Detected
    Summary
    Updated the page version from v3.0.2 to v3.1.0; previous version tag removed and new version tag added.
    Difference
    0.1%
    Check dated 2025-09-29T03:04:42.000Z thumbnail image
  6. Check
    63 days ago
    Change Detected
    Summary
    Revision updated to v3.0.2 and Back to Top removed; no core content or critical information is affected.
    Difference
    0.1%
    Check dated 2025-09-14T18:57:29.000Z thumbnail image
  7. Check
    70 days ago
    Change Detected
    Summary
    The web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content. There are no significant changes to core content, names, pricing, or availability.
    Difference
    0.1%
    Check dated 2025-09-07T14:11:24.000Z thumbnail image
  8. Check
    77 days ago
    Change Detected
    Summary
    The webpage has undergone significant updates, including the addition of numerous facility names and locations across various countries, particularly in Latin America and Europe, as well as new references to renal cell carcinoma research. Notably, several previous locations and terms have been removed, indicating a restructuring of the content.
    Difference
    17%
    Check dated 2025-08-31T11:38:52.000Z thumbnail image

Stay in the know with updates to Nivolumab & Cabozantinib vs Sunitinib in Renal Cell Carcinoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Nivolumab & Cabozantinib vs Sunitinib in Renal Cell Carcinoma Clinical Trial page.